Revisiting 5α-reductase inhibitors and the risk of prostate cancer

被引：10
|
作者：
Chau, Cindy H. [1 ]
Figg, William D. [1 ]
机构：
[1] NCI, Genitourinary Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
NATURE REVIEWS UROLOGY | 2018年 / 15卷 / 07期
基金：
美国国家卫生研究院;
关键词：
FINASTERIDE; MORTALITY; MEN;
D O I：
10.1038/s41585-018-0018-9
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The role of 5 alpha-reductase inhibitors (5-ARI) in prostate cancer chemoprevention remains a controversy, as cancer prevention trials with 5-ARIs have shown a decreased incidence of low-grade prostate cancer but a potential increased risk in high-grade disease. Recent studies have shed light on the long-term safety of 5-ARIs in terms of influencing prostate cancer risk.
引用
收藏
页码：400 / 401
页数：3
相关论文
共 50 条
  • [1] Revisiting 5α-reductase inhibitors and the risk of prostate cancer
    Cindy H. Chau
    William D. Figg
    [J]. Nature Reviews Urology, 2018, 15 : 400 - 401
  • [2] 5α-Reductase Inhibitors and Risk of Prostate Cancer Death
    Miranda, Tiago Bonde
    Garmo, Hans
    Stattin, Par
    Robinson, David
    [J]. JOURNAL OF UROLOGY, 2020, 204 (04): : 714 - 719
  • [3] Reduced Risk of Prostate Cancer With 5α-Reductase Inhibitors
    Thompson, Ian, Jr.
    Goodman, Phyllis
    Tangen, Catherine
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (11)
  • [4] Prostate cancer chemoprevention with 5α-reductase inhibitors
    Nepple, Kenneth G.
    Andriole, Gerald L.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (05) : 553 - 554
  • [5] 5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer
    Azoulay, Laurent
    Eberg, Maria
    Benayoun, Serge
    Pollak, Michael
    [J]. JAMA ONCOLOGY, 2015, 1 (03) : 314 - 320
  • [6] 5α-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction
    Rittmaster, Roger S.
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (02) : 389 - 402
  • [7] The continuing debate of 5-alpha reductase inhibitors and prostate cancer risk
    Faisal, Farzana A.
    Tosoian, Jeffrey J.
    [J]. TRANSLATIONAL CANCER RESEARCH, 2018, 7 (06) : 1344 - 1346
  • [8] Re: 5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men with Prostate Cancer
    Kaplan, Steven A.
    [J]. JOURNAL OF UROLOGY, 2016, 196 (05): : 1506 - 1506
  • [9] 5α-Reductase Inhibitors for Prostate-Cancer Prevention
    Kim, Jeri
    Amos, Christopher I.
    Logothetis, Christopher
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24): : 2340 - 2340
  • [10] 5-α Reductase Inhibitors and Prostate Cancer Mortality
    Hamilton, Robert J.
    Chavarriaga, Julian
    Khurram, Najia
    Lau, Cindy
    Luo, Jin
    Liu, Ning
    Komisarenko, Maria
    Kulkarni, Girish
    Wallis, Christopher
    Juurlink, David N.
    Fleshner, Neil
    Finelli, Antonio
    [J]. JAMA NETWORK OPEN, 2024, 7 (08)
12345